Inventor
DEWHIRST MARK
US13 patents
⚠️ This page may combine multiple inventors who share the name “DEWHIRST MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOLIGHT LLC
6 patentsUS9649832B2May 16, 2017
Adhesive bonding composition and method of use
IMMUNOLIGHT LLC4 citations80
US11207409B2Dec 28, 2021
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
IMMUNOLIGHT LLC3 citations70
US10441810B2Oct 15, 2019
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC3 citations70
US11865359B2Jan 9, 2024
Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
IMMUNOLIGHT LLC1 citations62
US11992697B2May 28, 2024
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC0 citations60
US11305131B2Apr 19, 2022
X-ray psoralen activated cancer therapy (X-PACT)
IMMUNOLIGHT LLC1 citations60
UNIV DUKE
3 patentsUS10253367B1Apr 9, 2019
Biomarkers for locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC)
UNIV DUKE2 citations62
US9937178B2Apr 10, 2018
Methods of identifying and using MDM2 inhibitors
UNIV DUKE0 citations43
US9771620B2Sep 26, 2017
Biomarkers of high-grade serous ovarian carcinomas
UNIV DUKE0 citations33
BIOMIMETIX JV LLC
2 patentsUS11285162B2Mar 29, 2022
Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure
BIOMIMETIX JV LLC2 citations68
US12171769B2Dec 24, 2024
Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure
BIOMIMETIX JV LLC0 citations57